UK markets closed
  • FTSE 100

    7,171.10
    +24.42 (+0.34%)
     
  • FTSE 250

    22,673.72
    -70.79 (-0.31%)
     
  • AIM

    1,243.66
    -7.30 (-0.58%)
     
  • GBP/EUR

    1.1616
    -0.0021 (-0.18%)
     
  • GBP/USD

    1.4085
    -0.0022 (-0.16%)
     
  • BTC-GBP

    28,353.32
    -578.44 (-2.00%)
     
  • CMC Crypto 200

    995.06
    -15.55 (-1.54%)
     
  • S&P 500

    4,241.46
    -13.69 (-0.32%)
     
  • DOW

    34,222.79
    -170.96 (-0.50%)
     
  • CRUDE OIL

    71.80
    +0.92 (+1.30%)
     
  • GOLD FUTURES

    1,862.00
    -3.90 (-0.21%)
     
  • NIKKEI 225

    29,441.30
    +279.50 (+0.96%)
     
  • HANG SENG

    28,638.53
    -203.60 (-0.71%)
     
  • DAX

    15,733.76
    +60.12 (+0.38%)
     
  • CAC 40

    6,642.60
    +26.25 (+0.40%)
     

Global Gastrointestinal Videoscopes Industry (2020 to 2027) - Market Trajectory & Analytics

·2-min read

Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Gastrointestinal Videoscopes - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Gastrointestinal Videoscopes estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$6.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.

Hospitals, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Clinics segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 8.6% CAGR

The Gastrointestinal Videoscopes market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Other Applications Segment to Record 4.5% CAGR

In the global Other Applications segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$631.8 Million in the year 2020 will reach a projected size of US$842.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$918.3 Million by the year 2027, while Latin America will expand at a 4.8% CAGR through the analysis period.

Select Competitors (Total 40 Featured):

  • Boston Scientific Corporation

  • Conmed Corporation

  • Covidien Ltd.

  • Fujinon Ltd

  • Johnson & Johnson Ltd.

  • Stryker Corporation;

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 40

For more information about this report visit https://www.researchandmarkets.com/r/apde2v

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900